Detrusor Overactivity and Urodynamics.
Nguyen LN, Nadeau G.
Neurourol Urodyn. 2026 Feb;45(2):279-285. doi: 10.1002/nau.70113. Epub 2025 Jul 3.
Detrusor overactivity: an overview.
Ashok K, Wang A.
Arch Gynecol Obstet. 2010 Jul;282(1):33-41. doi: 10.1007/s00404-010-1407-3. Epub 2010 Feb 27.
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu JN.
Eur Urol. 2019 Jun;75(6):988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26.
Are there different patterns of detrusor overactivity which are clinically relevant? ICI-RS 2018.
Gajewski JB, Gammie A, Speich J, Kirschner-Hermanns R, De Wachter S, Schurch B, Korstanje C, Valentini F, Rahnama'i MS.
Neurourol Urodyn. 2019 Dec;38 Suppl 5:S40-S45. doi: 10.1002/nau.23964.
Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Pro.
Denys P, Joussain C.
Prog Urol. 2023 Mar;33(4):174-175. doi: 10.1016/j.purol.2022.12.010. Epub 2023 Jan 7.
Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Cons.
Del Popolo G, Gemma L.
Prog Urol. 2023 Mar;33(4):176-177. doi: 10.1016/j.purol.2022.12.008. Epub 2023 Jan 2.
Coexistent Detrusor Overactivity-Underactivity in Patients with Pelvic Floor Disorders.
Frigerio M, Barba M, Marino G, Volontè S, Melocchi T, De Vicari D, Torella M, Salvatore S, Braga A, Serati M, Manodoro S, Cola A.
Healthcare (Basel). 2022 Sep 8;10(9):1720. doi: 10.3390/healthcare10091720.
Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.
Kaviani A, Khavari R.
Urol Clin North Am. 2017 Aug;44(3):463-474. doi: 10.1016/j.ucl.2017.04.012.
Overactivity index: A noninvasive and objective outcome measure in overactive bladder in children.
Abdovic S, Colic M, Stemberger Maric L, Cuk M, Hizar I, Milosevic M.
J Pediatr Urol. 2022 Jun;18(3):352.e1-352.e7. doi: 10.1016/j.jpurol.2022.03.012. Epub 2022 Apr 13.
Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
Sahai A, Khan MS, Gregson N, Smith K, Dasgupta P; GKT Botulinum Study Group.
Nat Clin Pract Urol. 2007 Jul;4(7):379-86. doi: 10.1038/ncpuro0839.
